Mr Andrea Bille

About Mr Andrea Bille

Mr Andrea Bille is a talented consultant thoracic surgeon at London Bridge Hospital and The Lister Hospital, which are both part of HCA Healthcare UK. He specialises in thoracic oncology, such as lung cancer, thymoma, mesothelioma, and Pancoast tumours. He has further expertise in other lung ailments and treatments including pneumothorax, airway disease and thoracic endometriosis. He also has expertise in robotic surgery having performed over 1,300 major robotic thoracic cases. Mr Bille has developed an interest in robotic surgery for diaphragmatic disease including diaphragmatic elevation paralysis and diaphragmatic endometriosis.He has an additional public practice at Guy’s and St Thomas’s NHS Foundation Trust. Mr Bille completed his degree in Medicine in 2005 before undergoing a speciality in Thoracic Surgery in 2011 at the University of Turin. He completed a clinical fellowship at Guy’s Hospital with a focus on mesothelioma surgery and minimally invasive thoracic surgery for the treatment of lung cancer and benign conditions. Mr Bille was then appointed as a locum consultant in thoracic surgery at the National Institute of Cancer in Milan in 2012, and in 2014 he undertook a fellowship with the renowned Memorial Sloan Kettering Cancer Center in New York City, USA, where he was trained in minimally-invasive treatments for thoracic malignancies and advance technique with complex reconstruction for locally advanced tumours. In 2015, he earned a PhD from the University of Milan for research on the surgical treatment of mesothelioma, a portion of which was published in the Thoracic Oncology Journal. Mr Bille’s passion for thoracic medicine is further exemplified by his appointment as Honorary Senior Clinical Reader as of 2021 in the Cancer division at King’s College London, and as chair of the European Society of Thoracic Surgery (ESTS) mesothelioma registry and Chair of the N staging foe mesothelioma (TNM 9th edition). He is an associate editor for the thoracic surgery section of the Tumori Journal, and he has attended and presented several studies on thoracic malignancies at international meetings, with over 60 abstracts having been accepted. He is a member of several esteemed medical organisations, including ESTS, the Royal College of Surgeons, and the International Association for the Study of Lung Cancer.